REFERENCES:

1) Bhatia V, Tandon RK. Stress and the gastrointestinal tract. Journal of gastroenterology and hepatology. 2005 Mar;20(3):332-9. [1]
2) El-Omar EM, Oien K, El-Nujumi A, Gillen D, Wirz A, Dahill S, Williams C, Ardill JE, McColl KE. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology. 1997 Jul 1;113(1):15-24.[6]
3) LA CORTE R, Caselli M, Castellino G, Trotta F. Helicobacter pylori and Non-Steroidal Anti- Inflammatory Drugs. GASTROENTEROLOGY INTERNATIONAL. 1997;10(Suppl. 4):35-6.
4) Malfertheiner P, Megraud F, O’Morain CA, Atherton J, Axon AT, Bazzoli F, Gensini GF, Gisbert JP, Graham DY, Rokkas T, El-Omar EM. Management of Helicobacter pylori infection— the Maastricht IV/Florence consensus report. Gut. 2012 May 1;61(5):646-64.
5) LA CORTE R, Caselli M, Castellino G, Trotta F. Helicobacter pylori and Non-Steroidal Anti- Inflammatory Drugs. GASTROENTEROLOGY INTERNATIONAL. 1997;10(Suppl. 4):35-6.
6) Lanza FL, Chan FK, Quigley EM, Practice Parameters Committee of the American College of Gastroenterology. Guidelines for prevention of NSAID-related ulcer complications. Official journal of the American College of Gastroenterology| ACG. 2009 Mar 1;104(3):728-38. Epidemiology
7) Chia JK, Chia AY. Acute gastritis associated with enterovirus infection. Archives of pathology & laboratory medicine. 2010 Jan 1;134(1):16-.
8) Yin Y, Liang H, Wei N, Zheng Z. Prevalence of chronic atrophic gastritis worldwide from 2010 to 2020: an updated systematic review and meta-analysis. Annals of Palliative Medicine. 2022 Dec;11(12):3697703-3703
9) Coati I, Fassan M, Farinati F, Graham DY, Genta RM, Rugge M. Autoimmune gastritis: Pathologist’s viewpoint. World journal of gastroenterology. 2015 Nov 14;21(42):12179..
10) Carmel R. Prevalence of undiagnosed pernicious anemia in the elderly. Archives of internal medicine. 1996 May 27;156(10):1097-100.
11) Mana F, Vandebosch S, Deyi VM, Haentjens P, Urbain D. Prevalence of and risk factors forH. pylori infection in healthy children and young adults in Belgium anno 2010/2011. Acta Gastro-Enterologica Belgica. 2013 Oct;76(4):381-5.
12) Goh KL, Chan WK, Shiota S, Yamaoka Y. Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter. 2011 Sep;16:1-9.
13) Park JS, Jun JS, Seo JH, Youn HS, Rhee KH. Changing prevalence of Helicobacter pylori infection in children and adolescents. Clinical and experimental pediatrics. 2020 Jul 15;64(1):21.
14) Chia JK, Chia AY. Acute gastritis associated with enterovirus infection. Archives of pathology & laboratory medicine. 2010 Jan 1;134(1):16-.
15) Sipponen P, Maaroos HI. Chronic gastritis. Scandinavian journal of gastroenterology. 2015 Jun 3;50(6):657-67.
16) Kayaçetin S, Güreşçi S. What is gastritis? What is gastropathy? How is it classified?. Turkish journal of gastroenterology. 2014;25(3):233-47.
17) Sipponen P, Maaroos HI. Chronic gastritis. Scandinavian journal of gastroenterology. 2015 Jun 3;50(6):657-67.
18) Chia JK, Chia AY. Acute gastritis associated with enterovirus infection. Archives of pathology & laboratory medicine. 2010 Jan 1;134(1):16-.
19) Pennelli G, Grillo F, Galuppini F, Ingravallo G, Pilozzi E, Rugge M, Fiocca R, Fassan M, Mastracci L. Gastritis: update on etiological features and histological practical approach.Pathologica. 2020 Oct 29;112(3):153.
20) Sipponen P, Price AB. The Sydney System for classification of gastritis 20 years ago. J Gastroenterol Hepatol. 2011 Jan;26 Suppl 1:31-4.Pathophysiology
21) Kayaçetin S, Güreşçi S. What is gastritis? What is gastropathy? How is it classified?. Turkish journal of gastroenterology. 2014;25(3):233-47.
22) Azuma T, Yamakawa A, Yamazaki S, Fukuta K, Ohtani M, Ito Y, Dojo M, Yamazaki Y, Kuriyama M. Correlation between variation of the 3′ region of the cagA gene in Helicobacter )pylori and disease outcome in Japan. The Journal of infectious diseases. 2002 Dec 1;186(11):1621-30.
23) Mobley HL. The role of Helicobacter pylori urease in the pathogenesis of gastritis and peptic ulceration. Alimentary pharmacology & therapeutics. 1996 Apr;10(Sup1):57-64.
24) )Kolopaking MS. Urease, gastric bacteria and gastritis. Acta Medica Indonesiana. 2022 Apr 8;54(1):1-.
25) Goodwin CS, Worsley BW. Microbiology of Helicobacter pylori. Gastroenterology Clinics of North America. 1993 Mar 1;22(1):5-19.
26) Di tommaso an, xiang z, bugnoli m, pileri p, figura n, bayeli pf, rappuoli r, abrignani s, de magistris mt. helicobacter pylori-specific cd4+ t-cell clones from peripheral blood and gastric biopsies. Infection and immunity. 1995 mar;63(3):1102-6.
27) Das S, Suarez G, Beswick EJ, Sierra JC, Graham DY, Reyes VE. Expression of B7-H1 on gastric epithelial cells: its potential role in regulating T cells during Helicobacter pylori infection. The Journal of Immunology. 2006 Mar 1;176(5):3000-9.
28) )Keates SA, Hitti YS, Upton ME, Kelly CP. Helicobacter pylori infection activates NF-kapa B in gastric epithelial cells. Gastroenterology. 1997 Oct 1;113(4):1099-109.
29) Väänänen H, Vauhkonen M, Helske T, Kääriäinen I, Rasmussen M, Tunturi-Hihnala H,
Koskenpato J, Sotka M, Turunen M, Sandström R, Ristikankare M. Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of
gastrin-17 and pepsinogen I: a multicentre study. European journal of gastroenterology & hepatology. 2003 Aug 1;15(8):885-91.
30) Yin Y, Liang H, Wei N, Zheng Z. Prevalence of chronic atrophic gastritis worldwide from 2010 to 2020: an updated systematic review and meta-analysis. Annals of Palliative Medicine. 2022 Dec;11(12):3697703-3703.
31) Mana F, Vandebosch S, Deyi VM, Haentjens P, Urbain D. Prevalence of and risk factors for H. pylori infection in healthy children and young adults in Belgium anno 2010/2011. Acta Gastro-Enterologica Belgica. 2013 Oct;76(4):381-5.
32) Goh KL, Chan WK, Shiota S, Yamaoka Y. Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter. 2011 Sep;16:1-9.
33) Park JS, Jun JS, Seo JH, Youn HS, Rhee KH. Changing prevalence of Helicobacter pylori infection in children and adolescents. Clinical and experimental pediatrics. 2020 Jul 15;64(1):21.
34) Sipponen P, Maaroos HI. Chronic gastritis. Scandinavian journal of gastroenterology. 2015 Jun 3;50(6):657-67.
35) Shah SC, Piazuelo MB, Kuipers EJ, Li D. AGA clinical practice update on the diagnosis and management of atrophic gastritis: expert review. Gastroenterology. 2021 Oct 1;161(4):1325-32.
36) Lanza FL, Chan FK, Quigley EM, Practice Parameters Committee of the American College of Gastroenterology. Guidelines for prevention of NSAID-related ulcer complications. Official journal of the American College of Gastroenterology| ACG. 2009 Mar 1;104(3):728-38
37) Marshall B, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. The lancet. 1984 Jun 16;323(8390):1311-5.
38) Väänänen H, Vauhkonen M, Helske T, Kääriäinen I, Rasmussen M, Tunturi-Hihnala H, Koskenpato J, Sotka M, Turunen M, Sandström R, Ristikankare M. Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels ofgastrin-17 and pepsinogen I: a multicentre study. European journal of gastroenterology & hepatology. 2003 Aug 1;15(8):885-91.
39) McDonald GB. Infections of the esophagus. Textbook of Clinical Gastroenterology and Hepatology. 2012 May 21:214.
40) Marshall, B. J., & Warren, J. R. (1984). Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. The Lancet, 323(8390), 1311–1315
41) Cover, T. L., & Blaser, M. J. (2009). Helicobacter pylori in health and disease. Gastroenterology, 136(6), 1863–1873. 24. Crew, K. D., & Neugut, A. I. (2006). Epidemiology
42) IARC A. Review of Human Carcinogens. Part F. Chemical Agents and Related Occupations. 2012;100.
43) El Rouby N, Lima JJ, Johnson JA. Proton pump inhibitors: from CYP2C19 pharmacogenetics to precision medicine. Expert opinion on drug metabolism & toxicology. 2018 Apr 3;14(4):447- 60.
44) Modak AS, Klyarytska I, Kriviy V, Tsapyak T, Rabotyagova Y. The effect of proton pump inhibitors on the CYP2C19 enzyme activity evaluated by the pantoprazole-13C breath test in GERD patients: clinical relevance for personalized medicine. Journal of Breath Research. 2016 Dec 16;10(4):046017.
44) El Rouby N, Lima JJ, Johnson JA. Proton pump inhibitors: from CYP2C19 pharmacogenetics to precision medicine. Expert opinion on drug metabolism & toxicology. 2018 Apr 3;14(4):447- 60.
45) Modak AS, Klyarytska I, Kriviy V, Tsapyak T, Rabotyagova Y. The effect of proton pump inhibitors on the CYP2C19 enzyme activity evaluated by the pantoprazole-13C breath test in GERD patients: clinical relevance for personalized medicine. Journal of Breath Research. 2016 Dec 16;10(4):046017.
46) Xie Y, Bowe B, Li T, Xian H, Yan Y, Al-Aly Z. Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury. Kidney international. 2017 Jun 1;91(6):1482-94(.cvs)
.47)Zhang Y, Liang M, Sun C, Song EJ, Cheng C, Shi T, et al. Proton pump inhibitors use and dementia risk: a meta-analysis of cohort studies. Eur J Clin Pharmacol. 2020;76:139–147. Doi: 10.1007/s00228-019-02753-7
48) https://www.healthline.com/health/gastritis-diet
49) https://www.medicalnewstoday.com/articles/gastritis-diet